APA (7th ed.) Citation

A, W., N, C., A, B., ML, W., P, H., I, G., . . . AB, M. (2023). Inhaled pirfenidone solution (AP01) for IPF: A randomised, open-label, dose-response trial. Thorax, 78(9), 882. https://doi.org/10.1136/thorax-2022-219391

Chicago Style (17th ed.) Citation

A, West, et al. "Inhaled Pirfenidone Solution (AP01) for IPF: A Randomised, Open-label, Dose-response Trial." Thorax 78, no. 9 (2023): 882. https://doi.org/10.1136/thorax-2022-219391.

MLA (9th ed.) Citation

A, West, et al. "Inhaled Pirfenidone Solution (AP01) for IPF: A Randomised, Open-label, Dose-response Trial." Thorax, vol. 78, no. 9, 2023, p. 882, https://doi.org/10.1136/thorax-2022-219391.